SYP and Parkinson disease: Experimental data support the existence of dynamic changes in axonal synaptic vesicle-associated proteins and alterations in retrograde transport that lead to changes in pre-synaptic markers like synaptophysin after LPS administration in Parkinson’s Disease, leading to the degeneration of dopaninergic neurons [75].